GlassScriptPhysician profile
Beau B Shay
NPI 1831351584
$18,678.30
in general payments reported to CMS, 2019-2025
15 companies · $2,386 in 2025
The $2,386 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,303 · 2020: $1,908 · 2021: $4,040 · 2022: $1,036 · 2023: $2,149 · 2024: $2,855 · 2025: $2,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,480 · Travel and Lodging: $1,839 · Consulting Fee: $71.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,480.19 |
| Travel and Lodging | $1,838.94 |
| Consulting Fee | $71.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,434.20 | 2021-2025 | Prophecy, Inbone, Invision |
| Wright Medical Technology, INC. | $3,690.49 | 2019 | |
| Arthrex, INC. | $3,053.68 | 2020-2024 | Arthrex |
| Wardlow Enterprises | $2,022.79 | 2019-2023 | |
| Depuy Synthes Sales INC. | $1,128.92 | 2019-2025 | Na, Motoband, Fibergraft Aeridyan Matrix |
| Prism Medical | $934.62 | 2024-2025 | |
| Kerecis Limited | $480.80 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axogen | $217.49 | 2020 | |
| Organogenesis INC. | $195.98 | 2021-2023 | Affinity, Puraply |
| Convatec INC. | $175.58 | 2019-2024 | |
| Orthofix Medical, INC. | $151.56 | 2024 | Physio-Stim |
| Next Science LLC | $71.28 | 2024 | Xperience, Blastx, Surgx |
| Avita Medical Americas, LLC | $48.42 | 2025 | Cohealyx, Recell, Permeaderm |
| Smith+Nephew, INC. | $45.87 | 2021-2022 | |
| Checkpoint Surgical, INC | $26.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beau Shay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.